Regulation and function of cyclin D2 in B lymphocyte subsets

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 2901-2907

  Chiles, Thomas C ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYCLIN D2; CYCLIN D3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; RAF PROTEIN;

ANTIBODY PRODUCTION; B CELL LYMPHOMA; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL LINEAGE; GENE CONTROL; GENE EXPRESSION; GENE REPLICATION; GENE TARGETING; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOPOIESIS; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INDUCTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 4344593761     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.2901     Document Type: Short Survey

References (91)

1. 1 events and regulation of cell proliferation. Science 246:603.
2. Craxton, A., K. L. Otipoby, A. Jiang, and E. A. Clark. 1999. Signal transduction pathways that regulate the fate of B lymphocytes. Adv. Immunol. 73:79.
3. Nevins, J. R. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:585.
4. Sherr, C. J. 2000. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60:3689.
5. 1 cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 12:676.
6. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077.
7. 1 cyclins. Cell 71:323.
8. Xiong, Y., T. Connolly, B. Futcher, and D. Beach. 1991. Human D-type cyclin. Cell 65:691.
9. 1 phase of the cell cycle. Cell 65:701.
10. Motokura, T., T. Bloom, H. G. Kim, H. Juppnet, J. V. Ruderman, H. M. Kronenberg, and A. Arnold. 1991. A novel cyclin encoded by the bcl1-linked candidate oncogene. Nature 350:512.
11. 1-phase progression. Genes Dev. 13:1501.
12. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131.
13. Kato, J.-Y., M. Matsuoka, D. K. Strom, and C. J. Sherr. 1994. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14:2713.
14. Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA 95:1091.
15. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669.
16. 1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:2402.
17. 1. J. Cell Biol. 125:625.
18. Tsutsui, T., B. Hesabi, D. S. Moons, P. P. Pandolfi, K. S. Hansel, A. Koff, and H. Kiyokawa. 1999. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol. Cell. Biol. 19:7011.
19. Sicinski, P., J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621.
20. Sicinski, P., J. L. Donaher, Y. Geng, S. B. Parker, H. Gardner, M. Y. Park, R. L. Robker, J. S. Richards, L. K. McGinnis, J. D. Biggers, et al. 1996. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470.
21. Fantl, V., G. Stamp, A. Andrews, I. Rosewell, and C. Dickson. 1995. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:2364.
22. Ciemerych, M. A., A. M. Kenney, E. Sicinska, I. Kaleszczynska, R. T. Bronson, D. H. Rowitch, H. Gardner, and P. Sicinski. 2002. Development of mice expressing a single D-type cyclin. Genes Dev. 16:3277.
23. Tanguay, D. A., and T. C. Chiles. 1996. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes. J. Immunol. 156:539.
24. Solvason, N., W. W. Wu, N. Kabra, X. Wu, E. Lees, and M. C. Howard. 1996. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J. Exp. Med. 184:407.
25. 1 cell cycle stage following delivery of complete versus partial activation stimuli. Mol. Immunol. 33:1139.
26. Brorson, K., M. Brunswick, S. Ezhevsky, D. G. Wei, R. Berg, D. Scott, and K. E. Stein. 1997. xid affects events leading to B cell cycle entry. J. Immunol. 159:135.
27. Lam, E. W., J. Glassford, L. Banerji, N. S. Thomas, P. Sicinski, and G. G. Klaus. 2000. Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. J. Biol. Chem. 275:3479.
28. Chen-Kiang, S. 2003. Cell cycle control of plasma cell differentiation and tumorigenesis. Immunol. Rev. 194:39.
29. Su, T. T., and D. J. Rawlings. 2002. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J. Immunol. 168:2101.
30. Su, T. T., B. Guo, B. Wei, J. Braun, and D. J. Rawlings. 2004. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol. Rev. 197: 161.
31. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:75.
32. Allman, D., R. C. Lindsley, W. DeMuth, K. Rudd, S. A. Shinton, and R. R. Hardy. 2001. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167:6834.
33. Chung, J. B., R. A. Sater, M. L. Fields, J. Erikson, and J. G. Monroe. 2002. CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals. Int. Immunol. 14:157.
34. 1 phase of the cell cycle in response to antigen receptor signaling. J. Immunol. 156:4562.
35. Solvason, N., W. W. Wu, D. Parry, D. Mahony, E. W. Lam, J. Glassford, G. G. Klaus, P. Sicinski, R. Weinberg, Y. J. Liu, et al. 2000. Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. Int. Immunol. 12:631.
36. Jena, N., M. Deng, E. Sicinska, P. Sicinski, and G. Q. Daley. 2002. Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells. Cancer Res. 62:535.
37. Mohamedali, A., I. Soeiro, N. C. Lea, J. Glassford, L. Banerji, G. J. Mufti, E. W.-F. Lam, and S. B. Thomas. 2003. Cyclin D2 controls B cell progenitor numbers. J. Leukocyte Biol. 74:1139.
38. Hoffmann, R., T. Seidl, M. Neeb, A. Rolink, and F. Melchers. 2002. Changes in gene expression profiles in developing B cells of murine bone marrow. Genome Res. 12:98.
39. Tanguay, D. A., T. P. Colarusso, S. Pavlovic, M. Irigoyen, R. G. Howard, J. Bartek, T. C. Chiles, and T. L. Rothstein. 1999. Early induction of cyclin D2 expression in phorbol estet-responsive B-1 lymphocytes. J. Exp. Med. 189:1685.
40. Tanguay, D. A., T. P. Colarusso, C. Doughty, S. Pavlovic, T. L. Rothstein, and T. C. Chiles. 2001. Differences in the signaling requirements for activation of assembled cyclin D3-cdk4 complexes in B-1 and B-2 lymphocytes. J. Immunol 166:4273.
41. Alizadeh, A. A., M. B. Eisen, R. E. Davis, C. Ma, I. S. Lossos, A. Rosenwald, J. C. Boldrick, H. Sabet, T. Tran, X. Yu, et al. 2000. Identification of molecularly and clinically distinct types of diffuse large B-cell lymphoma by gene expression profiling. Nature 403:503.
42. Shaffer, A. L., A. Rosenwald, E. M. Hurt, J. M. Gilmane, L. T. Lam, O. K. Picketal, and L. M. Staudt. 2001. Signatures of the immune response. Immunity 15:375.
43. Klein, U., Y. Tu, G. A. Stolovitzky, J. L. Keller, J. Haddad, Jr., V. Miljkovic, G. Cattoretti, A. Califano, and R. Dalla-Favera. 2003. Transcriptional analysis of the B cell germinal center reaction. Proc. Natl. Acad. Sci. USA 100:2639.
44. Shaffer, A. L., X. Yu, Y. He, J. Boldrick, E. P. Chan, and L. M. Staudt. 2000. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13:199.
45. Chleq-Deschamps, C. M., D. P. LeBrun, P. Huie, D. P. Besnier, R. A. Warnke, R. K. Sibley, and M. L. Cleary. 1993. Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. Blood 81:293.
46. Datar, S. A., H. W. Jacobs, A. F. de la Cruz, C. F. Lehner, and B. A. Edgar. 2000. The Drosophila cyclin D-Cdk4 complex promotes cellular growth. EMBO J. 19:4543.
47. Coqueret, O. 2002. Linking cyclins to transcriptional control. Gene 299:35.
48. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022.
49. Rao, S. S., C. Chu, and D. S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259.
50. 1 cyclins, D2 and D3, but not D1. Proc. Natl. Acad. Sci. USA 90:11513.
51. Forssell, J., A. Nilsson, and P. Sideras. 1999. Bruton's tyrosine-kinases-deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4. Scand. J. Immunol. 49:155.
52. Satterthwaite, A. B., and O. N. Witte. 2000. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. Immunol. Rev. 175:120.
53. Tan, J. E.-L., S.-W. Wong, S. K.-E. Gan, S. Xu, and K.-P. Lam. 2001. The adaptor protein BLNK is required for B cell antigen receptor-induced activation of nuclear factor-κB and cell cycle entry and survival of B lymphocytes. J. Biol. Chem. 276:20055.
54. Glassford, J., M. Holman, L. Banerji, E. Clayton, G. G. B. Klaus, M. Turner, and E. W.-F. Lam. 2001. Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen receptor. J. Biol Chem. 276:41040.
55. Richards, J. D., S. H. Dave, C.-H. G. Chou, A. A. Mamchak, and A. L. DeFranco. 2001. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen. J. Immunol. 166:3855.
56. 2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line. J. Immunol. 161:1637.
57. Graves, J. D., K. E. Draves, A. Craxton, J. Saklatvala, E. G. Krebs, and E. A. Clark. 1996. Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc. Natl. Acad. Sci. USA 93:13814.
58. Sutherland, C. L., A. W. Heath, S. L. Pelech, P. R. Young, and M. R. Gold. 1996. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J. Immunol. 157:3381.
59. Piatelli, M. J., C. Doughty, and T. C. Chiles. 2002. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes. J. Biol. Chem. 277:12144.
60. Jacob, A., D. Cooney, M. Pradhan, and K. M. Coggeshall. 2002. Convergence of signaling pathways on the activation of ERK in B cells. J. Biol. Chem. 277:23420.
61. Gold, M. R., J. S. Stewart, and S. L. Pelech. 1992. Selective activation of p42 mitogen-activated protein (MAP) kinase in murine B lymphoma cell lines by membrane immunoglobulin cross-linking: evidence for protein kinase C-independent and -dependent mechanisms of activation. Biochem. J. 287:269.
62. Han, A., K. Saijo, I. Mecklenbrauket, A. Tarakhovsky, and M. C. Nussenzweig. 2003. Bam32 links the B cell receptor to ERK and JNK and mediates B cell proliferation but not survival. Immunity 19:621.
63. Niito, H., A. Maeda, T. Kurosaki, and E. A. Clark. 2002. The B lymphocyte adaptor molecule of 32 kD (Bam32) regulates B cell antigen receptor signaling and cell survival. J. Exp. Med. 195:143.
64. Niito, H., and E. A. Clark. 2003. Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carmal. Immunity 19:637.
65. Fournier, E., S. J. Isakoff, K. Ko, C. J. Cardinale, G. G. Inghirami, Z. Li, M. A. Curotto de Lafaille, and E. Y. Skolnik. 2003. The B cell SH2/PH domain-containing adaptor Bam32/DAPP1 is required for T cell-independent II antigen responses. Curr. Biol. 13:1858.
66. Petro, J. B., S. M. Rahman, D. W. Ballard, and W. N. Khan. 2000. Bruton's tyrosine kinase is required for activation of IκB kinase and nuclear factor κB in response to B cell receptor engagement. J. Exp. Med. 191:1745.
67. Bajpai, U. D., K. Zhang, M. Teutsch, R. Sen, and H. H. Wortis. 2000. Bruton's tyrosine kinase links the B cell receptor to nuclear factor κB activation. J. Exp. Med. 191:1735.
68. Brennan, P., A. M. Mehl, M. Jones, and M. Rowe. 2002. Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells. Oncogene 21:1263.
69. Bone, H., and N. A. Williams. 2001. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-κB activation in primary B cells. Int. Immunol. 13:807.
70. Fruman, D. A., and L. C. Cantley. 2002. Phosphoinositide-3-kinase in immunological systems. Semin. Immunol. 14:7.
71. Suzuki, H., Y. Terauchi, M. Fujiwara, S. Aizawa, Y. Yazaki, T. Kadowaki, and S. Koyasu. 1999. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 283:390.
72. Fruman, D. A., S. B. Snapper, C. M. Yballe, L. Davidson, J. Y. Yu, F. W. Alt, and L. C. Cantley. 1999. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283:393.
73. Piatelli, M. J., C. Wardle, J. Blois, C. Doughty, B. R. Schram, T. L. Rothstein, and T. C. Chiles. 2004. Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-κB signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells. J. Immunol. 172:2753.
74. Glassford, J., I. Soeiro, S. M. Skarell, L. Banerji, M. Holman, G. G. B. Klaus, T. Kadowaki, S. Koyasu, and E. W.-F. Lam. 2003. BCR targets cyclin D2 via Btk and the p85α subunit of PI3-K to induce cell cycle progression in primary mouse B cells. Oncogene 22:2248.
75. Ozes, O. N., L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and D. B. Donner. 1999. NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 401:82.
76. Le Good, J. A., W. H. Ziegler, D. B. Parekh, D. R. Alessi, P. Cohen, and P. J. Parker. 1998. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281:2042.
77. Dutil, E. M., A. Toker, and A. C. Newton. 1998. Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr. Biol 8:1366.
78. Antony, P., J. B. Petro, G. Carlesso, N. P. Shinners, J. Lowe, and W. N. Khan. 2003. B cell receptor directs the activation of NFAT and NF-κB via distinct molecular mechanisms. Exp. Cell Res. 291:11.
79. Mecklenbräuker, I., K. Saijo, N.-Y. Zheng, M. Leitges, and A. Tarakhovsky. 2002. Protein kinase Cδ controls self-antigen-induced B-cell tolerance. Nature 416:860.
80. Saijo, K., I. Mecklenbrauker, A. Santan, M. Leitger, C. Schmedt, and A. Tarakhovsky. 2002. Protein kinase Cβ controls nuclear factor κB activation in B cells through selective regulation of the IκB.kinase α. J. Exp. Med. 195:1647.
81. Su, T. T., B. Guo, Y. Kawakami, K. Sommer, K. Chae, L. A. Humphries, R. M. Kato, S. Kang, L. Patrone, R. Wall, et al. 2002. PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3:780.
82. Lee, H., M. Arsura, M. Wu, M. P. Duyao, A. J. Buckler, and G. E. Sonenshein. 1995. Role of the Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med. 181:1169.
83. Grumont, R. J., A. Strasser, and S. Gerondakis. 2002. B cell growth is controlled by phosphatidylinositol 3-kinase-dependent induction of Rel/NF-κB regulated c-myc transcription. Mol. Cell 10:1283.
84. Coller, H. A., C. Grandori, P. Tamayo, T. Colbert, E. S. Lander, R. N. Eisenman, and T. R. Golub. 2000. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. USA 97:3260.
85. Bouchard, C., K. Thieke, A. Mairer, R. Saffrich, J. Hanley-Hyde, W. Ansorge, S. Reed, P. Sicinski, J. Bartek, and M. Eilers. 1999. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18:5321.
86. Bouchard, C., O. Dirtrich, A. Kiermaier, K. Dohmann, A. Menkel, M. Eilers, and B. Luscher. 2001. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev. 15:2042.
87. Moon, J. J., E. D. Rubio, A. Martino, A. Krumm, and B. H. Nelson. 2004. A permissive role for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor. J. Biol. Chem. 279:5520.
88. Martino, A., J. H. Holmes IV, J. D. Lord, J. J. Moon, and B. H. Nelson. 2001. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2. J. Immunol. 166:1723.
89. 1997. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma: the Non-Hodgkin's Lymphoma Classification Project. Blood 89:3909.
90. Davis, R. E., K. D. Brown, U. Siebenlist, and L. M. Staudt. 2001. Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 194:1861.
91. Brooks, A. R., D. Shiffman, C. S. Chan, E. E. Brooks, and P. G. Milner. 1996. Functional analysis of the human cyclin D2 and cyclin D3 promoters. J. Biol. Chem. 271:9090.